For more information call (888) LUHS-888.
Ellen R. Gaynor
Adults = 18 years old must have:
Histologically documented metastatic or unresectable transitional cell carcinoma of the urinary tract, with progressive metastatic or locally advanced disease.
ECOG performance status 0-1
Additional requirements in section 4 of the protocol
The purpose of this study is to see what effects, good and/or bad, the combination of gemcitabine, cisplatin and bevacizumab has on participants and their cancer.
(708) 327 - 3101